ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Action Plan Steering committee votes 13-0 To Return $14 Million To NCI for Research

November 15, 1996

Michael Atkins Named Deputy Director at Georgetown Lombardi Cancer Center

March 2, 2012

NCI programs: AIDS Malignancy Program gets new director, authority.

November 4, 2005

Large Study Finds No Survival Benefit Associated With Removal Of Ovaries

January 30, 2009

Myriad In Partnership To Market Products.

December 14, 2001

NIH Consensus Conference Concludes That MRI In “Unusually Rewarding,” Calls For More Studies

November 6, 1987